Related Experiment Video
Updated: Sep 13, 2025

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Treatment of Severe Incontinence-Associated Dermatitis Using Polymer Cyanoacrylate: A Report on Three Case Studies
Vivien Low-Clarke1,2,3, Apryl Repole-Li Vaccari1,2,3, Michelle Barakat-Johnson1,2,3
1Vivien Low-Clarke, MN, BSc, RN, Royal Prince Alfred Hospital, Sydney Local Health District and Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
Background:
Incontinence-associated dermatitis (IAD) is a painful skin condition resulting from prolonged exposure to moisture, friction, and irritants found in urine and feces. Category 2 IAD involves partial-thickness skin loss with open lesions, causing severe pain due to exposed nerve endings. Effective management in clinical settings is vital to alleviate discomfort and prevent secondary infections, though treatment options for severe IAD remain is limited despite its occurrence.
Cases:
We report the successful management of Category 2 IAD involving the dermis and subcutaneous layers in 3 patients using a polymer cyanoacrylate. This intervention provided a protective barrier, shielding the skin from moisture and irritants while promoting healing. All patients exhibited significant improvement in skin condition and reported reduced pain within weeks of initiating treatment.
Conclusion:
Each case demonstrated improvement in IAD, wound healing, and reduced pain. These case studies aim to inform clinicians about the potential benefits of polymer cyanoacrylate in the management of severe IAD.
More Related Videos
20:33A Case Series of Successful Abdominal Closure Utilizing a Novel Technique Combining a Mechanical Closure System with a Biologic Xenograft that Accelerates Wound Healing
Published on: July 4, 2019
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022